Community Outreach and Engagement

社区外展和参与

基本信息

  • 批准号:
    10674568
  • 负责人:
  • 金额:
    $ 7.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

COMMUNITY OUTREACH AND ENGAGEMENT (COE) PROJECT SUMMARY Community Outreach and Engagement (COE) has been an integral component of the Dan L Duncan Comprehensive Cancer Center (DLDCCC) since its inception in 2007 when the Office of Outreach and Health Disparities (OOHD) was established. Its main activity is to ensure that the diverse and medically underserved populations of the DLDCCC’s catchment area benefit from innovative outreach, education, screening, and primary prevention strategies. The OOHD has grown in scope and is charged with disseminating and implementing evidence-based interventions into practice, with over $10 million in grant funding from NCI, NIH, and the Cancer Prevention and Research Institute of Texas (CPRIT). The DLDCCC’s COE is led by the OOHD, which leverages over a decade of working with academic and community partners to promote cancer awareness and prevention in the catchment area, with particular focus on medically underserved and racial/ethnic minority populations. The COE serves as a driver for the translation of research from the Research Programs and Disease Working Groups into practice in the catchment area. The COE leads the characterization of the catchment area to define the cancer burden and identify efforts to address cancer disparities. Through expanded partnerships with CHI St. Luke’s and continued partnerships with Texas Children’s Hospital, the catchment area of the DLDCCC was recently expanded to include communities of the Houston, Texas Metropolitan Statistical Area (MSA), representing a diverse population of more than 7 million individuals. In our catchment area we have identified triple negative breast, prostate in African Americans, lung, colorectal, liver, cervix, HPV- and HIV-associated malignancies, and pediatric cancers as major cancer burdens and/or cancers that disproportionally affect our catchment area population. Obesity and underutilization of cancer screening were identified as risk factors. Over the next 5 years, the COE will: (1) Continuously monitor the cancer burden and risk factors in the DLDCCC catchment area and promote the engagement of research programs to address the cancer burden and disparities in the catchment area; (2) Engage the DLDCCC catchment area populations in cancer prevention, control, survivorship outreach, education, and research to reduce cancer burden and disparities in the catchment area; and (3) Disseminate and promote integration of evidence-based interventions and findings from research DLDCCC programs, locally (e.g., in our catchment area), regionally, nationally, and globally through outreach, collaboration, and policy. This work will be accomplished with guidance from our Community Advisory Board and in close collaboration with DLDCCC Programs. It will leverage the COE’s strong expertise in developing patient- centered educational resource, methods to address cancer disparities, and implementing and disseminating multi-pronged, evidence-based interventions into practice.
社区外展和参与(COE)项目摘要 社区外展和参与(COE)一直是丹L邓肯 综合癌症中心(DLDCCC)自2007年成立以来, 差异(OOHD)已建立。其主要活动是确保医疗服务不足的多样化人群 DLDCCC集水区的人口受益于创新的外展,教育,筛查, 一级预防战略。OOHD的范围已经扩大,并负责传播和 将循证干预措施付诸实践,来自NCI,NIH, 德克萨斯州癌症预防和研究所(CPRIT)。DLDCCC的COE由 OOHD,利用十多年与学术和社区合作伙伴的合作来促进癌症 在集水区提高认识和预防,特别注重医疗服务不足的问题, 种族/少数民族人口。COE是将研究从 研究计划和疾病工作组在集水区的实践。 COE领导对集水区进行表征,以确定癌症负担,并确定以下工作: 解决癌症差异。通过扩大与CHI St. Luke's的伙伴关系, 与德克萨斯州儿童医院合作,DLDCCC的服务范围最近扩大到包括 德克萨斯州休斯顿大都会统计区(MSA)的社区,代表了不同的人口, 超过700万人。在我们的集水区,我们已经确定了三阴性乳腺癌,前列腺癌, 非裔美国人、肺癌、结直肠癌、肝癌、宫颈癌、HPV和HIV相关恶性肿瘤和儿科癌症 作为主要的癌症负担和/或癌症,严重影响我们的集水区人口。肥胖 和癌症筛查利用不足被确定为风险因素。在未来5年,COE将:(1) 持续监测DLDCCC集水区的癌症负担和风险因素, 参与研究计划,以解决癌症负担和集水区的差异;(2) 让DLDCCC集水区人口参与癌症预防、控制、生存外展, 教育和研究,以减少癌症的负担和差距在集水区;和(3)传播 并促进循证干预措施与DLDCCC研究项目结果的整合, 局部地(例如,在我们的流域),区域,国家和全球通过推广,合作, 政策这项工作将在我们的社区咨询委员会的指导下完成, 与DLDCCC项目合作。它将利用COE在开发患者方面的强大专业知识- 集中的教育资源,解决癌症差异的方法,以及实施和传播 多管齐下的循证干预措施付诸实践。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rayne Helen Rouce其他文献

Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
  • DOI:
    10.1016/j.bbmt.2014.11.210
  • 发表时间:
    2015-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Rayne Helen Rouce;Serena K. Perna;Gayatri Vyas;Sandhya Sharma;Manasa Hiregange;Natalia Lapteva;Ann M. Leen;Helen E. Heslop;Cliona M. Rooney;Ifigenia Tzannou
  • 通讯作者:
    Ifigenia Tzannou

Rayne Helen Rouce的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rayne Helen Rouce', 18)}}的其他基金

BCM-TSU CURED Administration Core (AC)
BCM-TSU CURED 管理核心 (AC)
  • 批准号:
    10762266
  • 财政年份:
    2023
  • 资助金额:
    $ 7.37万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 7.37万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.37万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 7.37万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.37万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 7.37万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 7.37万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.37万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 7.37万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 7.37万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.37万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了